Business

Analysts’ Ratings Review: Hologic Inc (NASDAQ:HOLX)

Hologic Inc (NASDAQ:HOLX) shares traded -0.34% down during most recent session to reach at the closing price of $43.35. The stock exchanged hands 2.72 Million shares versus average trading capacity of 2.47 Million shares, yielding a market cap of $12.14 Billion. Wall Street analysts covering the stock are projecting that the stock will reach $47.53 within the next 52-weeks. The mean target projections are based on 15 opinions.

Taking a broader look brokerage firms’ analysts on the street with an expectant view have Hologic Inc (NASDAQ:HOLX) high price target of $53 and with a conservative view have low price target of $39.

Needham “Upgrades” Hologic Inc (NASDAQ:HOLX) in a research note issued to investors on 2/15/17 to Buy with price target of $0.

Additionally on 2/15/17 Bank of America “Downgrades” Hologic Inc (NASDAQ:HOLX) to Neutral setting price target at $0 and on 1/18/17 Deutsche Bank “Initiates Coverage On” the stock to Buy at $48. Furthermore on 1/17/17 Deutsche Bank “Initiates Coverage On” the stock to Buy at $48.

On the other hand the company has Relative Strength Index (RSI 14) of 47.31 along with Average True Range (ATR 14) of 0.71, Consequently Hologic Inc (NASDAQ:HOLX)’s weekly and monthly volatility is 1.35%, 1.47% respectively. The company’s beta value is at 0.95.

In terms of Buy, Sell or Hold recommendations, Hologic Inc (NASDAQ:HOLX) has analysts’ mean recommendation of 2. This is according to a simplified 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell.

According to analysts Hologic Inc (NASDAQ:HOLX)’s minimum EPS for the current quarter is at $0.48 and can go high up to $0.51. The consensus mean EPS for the current quarter is at $0.49 derived from a total of 16 estimates from the analysts who have weighed in on projected earnings. However the company reported $0.51 earnings per share for the same quarter during last year.

Previously Hologic Inc (NASDAQ:HOLX) reported $0.5 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.46 by $0.04. The company posted an earnings surprise of 8.7%.

While considering growth estimates of the company, it has next quarter growth estimates of -3.8% whereas during current quarter it has -3.9% estimations over growth, comparing to the estimations of 2.6% during current year and 10% for next year. Past 5 years growth of Hologic Inc (NASDAQ:HOLX) observed at 8.99%, looking forward for the next 5 years it has a strong prediction of 9.82% over growth.

Hologic Inc (NASDAQ:HOLX)’s revenue estimates for the current quarter are $798.81 Million according to 15 number of analysts, for the current quarter the company has high revenue estimates of $803 Million in contradiction of low revenue estimates of $790.8 Million. For the current year the company’s revenue estimates are $3.07 Billion compared to low analyst estimates of $3.05 Billion and high estimates of $3.08 Billion according to 18 number of analysts.

Currently Hologic Inc (NASDAQ:HOLX)’s shares owned by insiders are 0.5%, whereas shares owned by institutional owners are 99.5%. However the six-month change in the insider ownership was recorded -14.42%, as well as three-month change in the institutional ownership was recorded -0.15%.

Hologic Inc (NASDAQ:HOLX) 52-week high price stands at $46.05 and low price stands at $32.64, its price distance from 52-week high is -5.86% while its distance from 52-week low price is 32.81%. The stock hit its 52-week high on 05/10/17, and 52-week low on 06/16/16.

Hologic Inc (NASDAQ:HOLX)’s trailing twelve month revenues are $2.89 Billion, whereas its price to sales ratio for the same period is 4.21. Its book value per share for the most recent quarter is $9.98 while its price to book ratio for the same period is 4.34, as for as the company’s cash per share for the most recent quarter is $4.06, however its price to cash per share ratio for the same period is 10.69. The stock has 5 year expected PEG ratio of 1.59 whereas its trailing twelve month P/E ratio is 15.63.

Previous ArticleNext Article